<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Pharmadrug Inc. — News on 6ix</title>
<link>https://6ix.com/company/pharmadrug-inc</link>
<description>Latest news and press releases for Pharmadrug Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 05 Jan 2026 13:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/pharmadrug-inc" rel="self" type="application/rss+xml" />
<item>
<title>PharmaDrug Completes Acquisition of Initial 19.9% Interest in Canurta Inc. and Completes Debt Restructuring</title>
<link>https://6ix.com/company/pharmadrug-inc/news/pharmadrug-completes-acquisition-initial-19-130000070</link>
<guid isPermaLink="true">https://6ix.com/company/pharmadrug-inc/news/pharmadrug-completes-acquisition-initial-19-130000070</guid>
<pubDate>Mon, 05 Jan 2026 13:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - January 5, 2026) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of natural medicines is pleased to announce that it has closed the previously announced (see press release dated October 31, 2025) acquisition (the "Transaction") of limited partnership units of Canurta Limited Partnership ("Canurta"), the parent entity of Canurta Inc., a</description>
</item>
<item>
<title>PharmaDrug Announces Debt Restructuring</title>
<link>https://6ix.com/company/pharmadrug-inc/news/pharmadrug-announces-debt-restructuring-125800382</link>
<guid isPermaLink="true">https://6ix.com/company/pharmadrug-inc/news/pharmadrug-announces-debt-restructuring-125800382</guid>
<pubDate>Fri, 31 Oct 2025 12:58:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - October 31, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of natural medicines is pleased to announce that it has agreed to issue $445,686 principal amount of secured convertible debentures to two current holders of the Company's secured convertible debentures that were past their maturity date.Each Debenture will mature on...</description>
</item>
<item>
<title>PharmaDrug Signs Definitive Agreement to Acquire Equity Interest in Canurta Inc</title>
<link>https://6ix.com/company/pharmadrug-inc/news/pharmadrug-signs-definitive-agreement-acquire-130000174</link>
<guid isPermaLink="true">https://6ix.com/company/pharmadrug-inc/news/pharmadrug-signs-definitive-agreement-acquire-130000174</guid>
<pubDate>Thu, 30 Oct 2025 13:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - October 30, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of natural medicines is pleased to announce that it has executed a definitive securities exchange agreement (the "Definitive Agreement") with Canurta Limited Partnership ("Canurta") and each of the limited partners of Canurta, the parent entity of Canurta Inc., a...</description>
</item>
<item>
<title>PharmaDrug Inc.: Correction to News Release Dated July 30, 2025</title>
<link>https://6ix.com/company/pharmadrug-inc/news/pharmadrug-inc-correction-news-release-153700453</link>
<guid isPermaLink="true">https://6ix.com/company/pharmadrug-inc/news/pharmadrug-inc-correction-news-release-153700453</guid>
<pubDate>Wed, 30 Jul 2025 15:37:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - July 30, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), announces that the original news release captioned "PharmaDrug Signs LOI to Acquire Equity Interest in Canurta Inc." published on July 30, 2025 referred, incorrectly, to the number of common shares of PharmaDrug to be issued in the second tranche of the proposed transaction and the total number of shares to be issued pursuant to both ...</description>
</item>
<item>
<title>PharmaDrug Signs LOI to Acquire Equity Interest in Canurta Inc.</title>
<link>https://6ix.com/company/pharmadrug-inc/news/pharmadrug-signs-loi-acquire-equity-113000685</link>
<guid isPermaLink="true">https://6ix.com/company/pharmadrug-inc/news/pharmadrug-signs-loi-acquire-equity-113000685</guid>
<pubDate>Wed, 30 Jul 2025 11:30:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - July 30, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of natural medicines is announcing that it has entered into a non-binding Letter of Intent ("LOI") on July 23rd, 2025 to acquire up to a 40% equity interest in Canurta Limited Partnership ("Canurta"), the parent entity of Canurta Inc. (the "Transaction"), a biotechnology co</description>
</item>
<item>
<title>PharmaDrug Announces Resignation of Rob Steen as CEO and From Board of Directors</title>
<link>https://6ix.com/company/pharmadrug-inc/news/pharmadrug-announces-resignation-rob-steen-130400793</link>
<guid isPermaLink="true">https://6ix.com/company/pharmadrug-inc/news/pharmadrug-announces-resignation-rob-steen-130400793</guid>
<pubDate>Mon, 16 Jun 2025 13:04:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - June 16, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and previously approved drugs, is announcing that Rob Steen has resigned as CEO and from the board of directors of the Company effective immediately. Chairman David Kideckel will step into the role of Execu</description>
</item>
<item>
<title>PharmaDrug Announces Strategic Review Process Intended to Maximize Shareholder Value</title>
<link>https://6ix.com/company/pharmadrug-inc/news/pharmadrug-announces-strategic-review-process-120000355</link>
<guid isPermaLink="true">https://6ix.com/company/pharmadrug-inc/news/pharmadrug-announces-strategic-review-process-120000355</guid>
<pubDate>Fri, 06 Jun 2025 12:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - June 6, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and previously approved drugs, is announcing that the board of directors ("the Board") has formed a special committee of independent directors to lead a comprehensive strategic review process to consider opp</description>
</item>
<item>
<title>PharmaDrug's SecureDose Announces Filing of US Provisional Patent for Manufacturing Method for Biosynthetic Pharmaceutical Grade Cocaine</title>
<link>https://6ix.com/company/pharmadrug-inc/news/pharmadrugs-securedose-announces-filing-of-us-provisional-patent-for-manufacturing-method-for-biosynthetic-pharmaceutical-grade-cocaine</link>
<guid isPermaLink="true">https://6ix.com/company/pharmadrug-inc/news/pharmadrugs-securedose-announces-filing-of-us-provisional-patent-for-manufacturing-method-for-biosynthetic-pharmaceutical-grade-cocaine</guid>
<pubDate>Wed, 13 Mar 2024 11:30:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - March 13, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC PINK: LMLL...</description>
</item>
<item>
<title>PharmaDrug Appoints Current Board Member Dr. David Kideckel as Chairman</title>
<link>https://6ix.com/company/pharmadrug-inc/news/pharmadrug-appoints-current-board-member-dr-david-kideckel-as-chairman</link>
<guid isPermaLink="true">https://6ix.com/company/pharmadrug-inc/news/pharmadrug-appoints-current-board-member-dr-david-kideckel-as-chairman</guid>
<pubDate>Tue, 27 Feb 2024 13:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - February 27, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: L...</description>
</item>
<item>
<title>PharmaDrug's Sairiyo Successfully Demonstrates Ability to Manufacture Cepharanthine (PD-001) for Human Clinical Studies</title>
<link>https://6ix.com/company/pharmadrug-inc/news/pharmadrugs-sairiyo-successfully-demonstrates-ability-to-manufacture-cepharanthine-pd-001-for-human-clinical-studies</link>
<guid isPermaLink="true">https://6ix.com/company/pharmadrug-inc/news/pharmadrugs-sairiyo-successfully-demonstrates-ability-to-manufacture-cepharanthine-pd-001-for-human-clinical-studies</guid>
<pubDate>Wed, 14 Feb 2024 13:25:00 GMT</pubDate>
<description>Company to pursue regulatory filing for Phase I/II clinical study Toronto, Ontario--(Newsfile Co...</description>
</item>
<item>
<title>PharmaDrug Inc. Engages Investor Relations and Marketing Service Providers</title>
<link>https://6ix.com/company/pharmadrug-inc/news/pharmadrug-inc-engages-investor-relations-and-marketing-service-providers</link>
<guid isPermaLink="true">https://6ix.com/company/pharmadrug-inc/news/pharmadrug-inc-engages-investor-relations-and-marketing-service-providers</guid>
<pubDate>Mon, 12 Feb 2024 13:44:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - February 12, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: L...</description>
</item>
<item>
<title>PharmaDrug Inc. Announces Successful Closing of Non-Brokered Private Placement</title>
<link>https://6ix.com/company/pharmadrug-inc/news/pharmadrug-inc-announces-successful-closing-of-non-brokered-private-placement</link>
<guid isPermaLink="true">https://6ix.com/company/pharmadrug-inc/news/pharmadrug-inc-announces-successful-closing-of-non-brokered-private-placement</guid>
<pubDate>Thu, 08 Feb 2024 21:30:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - February 8, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LM...</description>
</item>
<item>
<title>PharmaDrug Inc. Announces Proposed Non-Brokered Private Placement</title>
<link>https://6ix.com/company/pharmadrug-inc/news/pharmadrug-inc-announces-proposed-non-brokered-private-placement</link>
<guid isPermaLink="true">https://6ix.com/company/pharmadrug-inc/news/pharmadrug-inc-announces-proposed-non-brokered-private-placement</guid>
<pubDate>Thu, 01 Feb 2024 13:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - February 1, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LM...</description>
</item>
<item>
<title>PharmaDrug CEO Provides Vision for Securedose Acquisition</title>
<link>https://6ix.com/company/pharmadrug-inc/news/pharmadrug-ceo-provides-vision-for-securedose-acquisition</link>
<guid isPermaLink="true">https://6ix.com/company/pharmadrug-inc/news/pharmadrug-ceo-provides-vision-for-securedose-acquisition</guid>
<pubDate>Wed, 13 Dec 2023 13:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - December 13, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: L...</description>
</item>
<item>
<title>PharmaDrug Inc. Completes Debt Restructuring</title>
<link>https://6ix.com/company/pharmadrug-inc/news/pharmadrug-inc-completes-debt-restructuring</link>
<guid isPermaLink="true">https://6ix.com/company/pharmadrug-inc/news/pharmadrug-inc-completes-debt-restructuring</guid>
<pubDate>Wed, 15 Nov 2023 13:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - November 15, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: L...</description>
</item>
<item>
<title>PharmaDrug Inc. Announces Grant of Stock Options</title>
<link>https://6ix.com/company/pharmadrug-inc/news/pharmadrug-inc-announces-grant-of-stock-options</link>
<guid isPermaLink="true">https://6ix.com/company/pharmadrug-inc/news/pharmadrug-inc-announces-grant-of-stock-options</guid>
<pubDate>Wed, 08 Nov 2023 22:23:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - November 8, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LM...</description>
</item>
<item>
<title>PharmaDrug Inc. Closes Acqusition of Securedose Synthetics</title>
<link>https://6ix.com/company/pharmadrug-inc/news/pharmadrug-inc-closes-acqusition-of-securedose-synthetics</link>
<guid isPermaLink="true">https://6ix.com/company/pharmadrug-inc/news/pharmadrug-inc-closes-acqusition-of-securedose-synthetics</guid>
<pubDate>Tue, 07 Nov 2023 12:30:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - November 7, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LM...</description>
</item>
<item>
<title>PharmaDrug Inc. Enters Definitive Agreement to Acquire SecureDose Synthetics</title>
<link>https://6ix.com/company/pharmadrug-inc/news/pharmadrug-inc-enters-definitive-agreement-to-acquire-securedose-synthetics</link>
<guid isPermaLink="true">https://6ix.com/company/pharmadrug-inc/news/pharmadrug-inc-enters-definitive-agreement-to-acquire-securedose-synthetics</guid>
<pubDate>Fri, 27 Oct 2023 11:30:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - October 27, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LM...</description>
</item>
<item>
<title>PharmaDrug Announces Share Consolidation and Change to Chief Financial Officer</title>
<link>https://6ix.com/company/pharmadrug-inc/news/pharmadrug-announces-share-consolidation-and-change-to-chief-financial-officer</link>
<guid isPermaLink="true">https://6ix.com/company/pharmadrug-inc/news/pharmadrug-announces-share-consolidation-and-change-to-chief-financial-officer</guid>
<pubDate>Fri, 20 Oct 2023 18:03:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - October 20, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF...</description>
</item>
<item>
<title>PharmaDrug Announces Amendment to Shareholder Meeting Matter</title>
<link>https://6ix.com/company/pharmadrug-inc/news/pharmadrug-announces-amendment-to-shareholder-meeting-matter</link>
<guid isPermaLink="true">https://6ix.com/company/pharmadrug-inc/news/pharmadrug-announces-amendment-to-shareholder-meeting-matter</guid>
<pubDate>Tue, 19 Sep 2023 20:05:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - September 19, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LML...</description>
</item>
</channel>
</rss>